Transplant Diagnostics Market Worth $645.0 Million by 2019 — DALLAS, March 25, 2015 /PRNewswir


DALLAS, March 25, 2015 /PRNewswire/ —

According to a new market research report “Transplant Diagnostics Market by Technology (Serological, SSO- & SSP-PCR, Sanger Sequencing, NGS), Product (Instrument, Reagent, Software), End User (Hospitals, Transplant Centers, Academia), Application (Diagnostic, Research) – Global Forecasts to 2019”, published by MarketsandMarkets, the global Transplant Diagnostics Market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of $645.0 Million in 2019.

Browse 79 market data tables and 56 figures spread through 180 pages and in-depth TOC on “Transplant Diagnostics Market”

http://www.marketsandmarkets.com/Market-Reports/transplant-diagnostics-market-96374742.html

Early buyers will receive 10% customization on this report.

Based on the type of technology, the global Transplant Diagnostics Market is classified into two major segments, namely, non-molecular assay technology (serological and mixed lymphocyte culture assay) and molecular assay technology (PCR and sequencing-based techniques) segments. Moreover, based on type of products, the global Transplant Diagnostics Market is classified into three product segments, namely, instruments, reagents and consumables, and software and services.

The global Transplant Diagnostics Market is further classified into three end user segments, namely hospitals and transplant centers, research laboratories and academic institutes, and commercial service providers. Additionally, the global Transplant Diagnostics Market is segmented based on applications into diagnostic applications and research applications.

Inquiry before Buying:  http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=96374742

As of 2014, North America holds the largest share of the Transplant Diagnostics Market, followed by Europe. However, the Asia-Pacific market is expected to grow at highest CAGR during 2014 to 2019. A number of factors such as increasing focus of global life science companies in emerging markets, growing public and private support to develop novel HLA typing technologies, and strengthening healthcare infrastructure across the APAC are stimulating the growth of the Transplant Diagnostics Market in the Asia-Pacific region.

Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche, Ltd. (Switzerland), Illumina, Inc. (U.S.), Immucor, Inc. (U.S.), Linkage Biosciences (U.S.), Olerup Ssp Ab (Norway), Qiagen N.V. (Netherlands), Sigma-Aldrich (U.S.), and Thermo Fisher Scientific Inc. (U.S.) are the major players in the global Transplant Diagnostics Market.

Read more via Transplant Diagnostics Market Worth $645.0 Million by 2019 — DALLAS, March 25, 2015 /PRNewswire/ —.

0 views
 

©2020 by Transplant Families, Inc.  All rights reserved.  Transplant Families is a 501(c)(3) non-profit organization.